Loews Corp acquired a new position in Monsanto Company (NYSE:MON) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,705 shares of the basic materials company’s stock, valued at approximately $202,000.

A number of other institutional investors have also made changes to their positions in the stock. BT Investment Management Ltd purchased a new stake in shares of Monsanto during the 2nd quarter worth about $4,292,000. Destination Wealth Management raised its stake in shares of Monsanto by 1.3% during the 2nd quarter. Destination Wealth Management now owns 79,982 shares of the basic materials company’s stock worth $9,467,000 after purchasing an additional 1,043 shares in the last quarter. Amalgamated Bank raised its stake in shares of Monsanto by 60.9% during the 2nd quarter. Amalgamated Bank now owns 51,887 shares of the basic materials company’s stock worth $6,141,000 after purchasing an additional 19,636 shares in the last quarter. Forbes J M & Co. LLP raised its stake in shares of Monsanto by 15.2% during the 2nd quarter. Forbes J M & Co. LLP now owns 2,212 shares of the basic materials company’s stock worth $261,000 after purchasing an additional 292 shares in the last quarter. Finally, BlackRock Inc. raised its stake in shares of Monsanto by 6.5% during the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after purchasing an additional 1,705,439 shares in the last quarter. 74.78% of the stock is owned by hedge funds and other institutional investors.

In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares in the company, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. 0.79% of the stock is owned by corporate insiders.

Shares of Monsanto Company (MON) opened at 119.40 on Friday. The firm has a 50-day moving average price of $117.37 and a 200-day moving average price of $116.53. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $119.60. The firm has a market cap of $52.46 billion, a price-to-earnings ratio of 25.79 and a beta of 1.07.

Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.17 earnings per share. Equities research analysts anticipate that Monsanto Company will post $4.89 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.81%. Monsanto’s dividend payout ratio is 46.75%.

ILLEGAL ACTIVITY WARNING: This article was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/09/22/loews-corp-invests-202000-in-monsanto-company-mon-stock.html.

A number of equities research analysts have recently weighed in on MON shares. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target for the company in a research note on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research note on Wednesday, July 12th. UBS AG downgraded Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target for the company. in a research note on Friday, August 18th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $128.00 price target (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Ten analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $124.09.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.